Oxford Biomedica Attracts Approach From PE Group EQT
Biotechnology company Oxford Biomedica PLC has said that it has received an unsolicited approach from a Swedish private equity group, EQT AB, that could lead to a possible cash offer....To view the full article, register now.
Already a subscriber? Click here to view full article